Last €68.35 EUR
Change Today -1.26 / -1.81%
Volume 714.8K
UCB On Other Exchanges
EN Brussels
As of 11:35 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by UCB SA (UCB) in the last 6 months

Announced 11/7/14
1.53B for Kremers Urban Pharmaceuticals Inc.

Advent International Corporation and Avista Capital Holdings, L.P. signed an agreement to acquire Kremers Urban Pharmaceuticals Inc. from UCB SA (ENXTBR:UCB) for $1.5 billion in cash on November 7, 2014. The deal financing is provided by Credit Suisse Securities LLC, Morgan Stanley & Co. LLC, Goldman, Sachs & Co and Jefferies LLC. Brian Markison, a healthcare Industry Executive at Avista, will become President and Chief Executive Officer of Kremers Urban. The transaction ...
Read More

UCB's price was unchanged after the transaction was announced on 11/7/14.
Investor / Buyer
Advent International Corporation
Avista Capital Holdings, L.P.
Creditor / Lender
Announced 09/19/14
8.00M for Dermira, Inc.
Private Placement

Dermira, Inc. (NasdaqGS:DERM) announced that it has entered into a common stock purchase agreement for the private placement of 468,750 shares at a price of $16 per share for gross proceeds of $7,500,000 on September 19, 2014.The company will not pay any underwriting discounts or commissions with respect to the shares. The securities will be issued to the existing investor UCB SA. The investor invested through its affiliate, UCB Pharma S.A.

UCB's price was unchanged after the transaction was announced on 09/19/14.
Investor / Buyer

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €68.35 EUR -1.26

UCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $85.60 USD +0.36
Grifols SA €36.26 EUR -0.465
Hospira Inc $87.54 USD 0.00
Sigma-Aldrich Corp $138.06 USD 0.00
Valspar Corp/The $86.65 USD +0.33
View Industry Companies

Industry Analysis


Industry Average

Valuation UCB Industry Range
Price/Earnings 37.0x
Price/Sales 3.0x
Price/Book 2.2x
Price/Cash Flow 38.2x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at